NCT07304323 is a clinical trial of Functional rehabilitation in HIP AND KNEE OSTEOARTHRITIS, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

Who is sponsoring NCT07304323?

NCT07304323 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What drugs are being tested in NCT07304323?

Interventions in NCT07304323: Functional rehabilitation.

What condition does NCT07304323 study?

NCT07304323 studies HIP AND KNEE OSTEOARTHRITIS.

Is NCT07304323 still recruiting?

NCT07304323 is currently recruiting now. Last updated 26 December 2025.

Last reviewed 2025-12-26 · How we verify

NCT07304323

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prepare II - Predictive Model Training and External Validation

Recruiting now Last updated 26 December 2025

What this trial tests

trial testing Functional rehabilitation in HIP AND KNEE OSTEOARTHRITIS in 400 participants. Currently enrolling.

Timeline

8 October 2025

Primary endpoint
31 October 2026

31 October 2026

Quick facts

Lead sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	400
Start date	8 October 2025
Primary completion	31 October 2026
Estimated completion	31 October 2026
Sites	1 location across Italy

Drugs / interventions tested

Functional rehabilitation

Conditions studied

HIP AND KNEE OSTEOARTHRITIS — all drugs for HIP AND KNEE OSTEOARTHRITIS →

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

18 and older, any sex, with HIP AND KNEE OSTEOARTHRITIS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The general aim of the project is training and testing a predictive model of inpatient rehabilitation stay after hip and knee replacement for osteoarthritis. This specific part focuses on data collection and analysis for the model validation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting
NCT07290920 — Sensorimotor Integration in Patients With Tourette Syndrome · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07304323 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Last refreshed: 26 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07304323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing